NPI: 1619945946 · PALM COAST, FL 32137 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,047 | $1.42M |
| 2019 | 11,752 | $1.80M |
| 2020 | 15,391 | $1.99M |
| 2021 | 8,775 | $788K |
| 2022 | 4,295 | $730K |
| 2023 | 322 | $41K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,888 | 1,149 | $2.48M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,871 | 812 | $2.11M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,534 | 643 | $895K |
| A4657 | Syringe, with or without needle, each | 1,604 | 880 | $390K |
| 83550 | 1,062 | 741 | $145K | |
| 83540 | 1,046 | 729 | $145K | |
| 85041 | 957 | 641 | $140K | |
| 85048 | 895 | 599 | $139K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,122 | 397 | $130K |
| 83970 | 565 | 328 | $81K | |
| 82728 | 345 | 243 | $48K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 187 | 129 | $20K |
| 82607 | 165 | 112 | $17K | |
| 82746 | 151 | 104 | $17K | |
| J1756 | Injection, iron sucrose, 1 mg | 94 | 15 | $10K |
| 82108 | 60 | 46 | $7K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 36 | 12 | $0.00 |